Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
220,352,492
-
Total 13F shares
-
127,014,197
-
Share change
-
+2,114,963
-
Total reported value
-
$1,964,665,169
-
Put/Call ratio
-
43%
-
Price per share
-
$15.47
-
Number of holders
-
236
-
Value change
-
+$120,987,021
-
Number of buys
-
148
-
Number of sells
-
93
Institutional Holders of Hims & Hers Health, Inc. - Common Stock (HIMS) as of Q1 2024
As of 31 Mar 2024,
Hims & Hers Health, Inc. - Common Stock (HIMS) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,014,197 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MARSHALL WACE, LLP, Institutional Venture Management XVI, LLC, Institutional Venture Management XV, LLC, Redpoint Management, LLC, BIT Capital GmbH, NewView Capital Partners I, LLC, Nuveen Asset Management, LLC, and Foresite Capital Management V, LLC.
This page lists
236
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.